IFNA1 and COVID-19: Recent studies also indicated that the human ACE2 gene can be induced through epigenetic regulation by chronic IFN and inflammatory signaling (48, 129), implying that these cells can become more susceptible during severe COVID-19 progression in obese patients who have low-grade inflammation and detrimentally chronic IFN responses (48, 129–132).